Literature DB >> 35570858

Asymptomatic gangrenous cholecystitis diagnosed using contrast-enhanced ultrasonography in a patient with pancreatic cancer.

Ryo Katsumata1, Noriaki Manabe2, Takashi Urano3, Tomohiro Tanikawa1, Katsunori Ishii1, Maki Ayaki2, Minoru Fujita2, Mitsuhiko Suehiro1, Hideyo Fujiwara4, Yasumasa Monobe4, Tomoari Kamada5, Tomoki Yamatsuji3, Yoshio Naomoto3, Ken Haruma1, Hirofumi Kawamoto1.   

Abstract

A 72-year-old female without abdominal symptoms visited our hospital for routine follow-up while undergoing pancreatic cancer treatment (using TS-1). Her vital signs were normal, and her abdomen was soft and non-tender. Blood test revealed elevated C-reactive protein levels with normal white blood cell count. Computed tomography was performed for follow-up of pancreatic cancer. Contrast-enhanced computed tomography showed partial discontinuity and irregular thickness of the gallbladder wall; however, a definitive diagnosis was not obtained due to unclear imaging. Contrast-enhanced transabdominal ultrasonography revealed intraluminal membranes in the gallbladder and a perfusion defect at the bottom, indicating gangrenous cholecystitis. Surgical resection was performed, and pathological examination showed severe necrosis of the gallbladder wall, consistent with the findings of contrast-enhanced transabdominal ultrasonography.
© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  Asymptomatic diseases; Gallbladder; Gangrenous cholecystitis; Transabdominal ultrasonography

Year:  2022        PMID: 35570858      PMCID: PMC9095665          DOI: 10.1016/j.radcr.2022.04.002

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Gangrenous cholecystitis (GC) was first described in 1894, and is defined as a severe form of acute cholecystitis (AC) with ischemia and necrosis of the gallbladder wall [1]. The prevalence of GC in AC has been reported to be 2%-40% [2]. Since this condition leads to life-threatening complications such as perforation, abscess formation, and peritonitis [3], leading to high mortality [2], accurate diagnosis and prompt surgical treatment are required. These patients generally present with intense abdominal symptoms such as abdominal pain; however, previous studies have reported that several patients with diabetes mellitus (DM) [4,5] and older patients [6] can develop GC without severe abdominal symptoms. GC can be suspected based on clinical findings including abdominal pain, fever, and inflammatory markers detected in blood tests, and diagnosed by computed tomography (CT) [7], transabdominal ultrasonography (US) [8,9], and magnetic resonance cholangiopancreatography [10,11]. Specific findings of GC include wall projections into the lumen, intraluminal membranes, and decreased enhancement of the gallbladder wall [7], [8], [9], [10], [11]. DM, cardiovascular disease (CVD), white blood cell count (WBC) ≥ 15,000 cells/μL at diagnosis, and increased age are known risk factors of GC [12,13]. Despite several predictive factors and diagnostic options, preoperative diagnosis of GC is difficult partly due to its atypical presentation [14] and less frequently presented characteristic findings such as intraluminal membranes [15]. Moreover, we have occasionally encountered cases in which contrast media cannot be adopted due to renal dysfunction or allergic reactions, resulting in inadequate imaging information for the diagnosis of GC. Surgical treatment is mainly required for GC to avoid fatal complications, although the suitability of laparoscopic or open cholecystectomy is still controversial [2]. In this report, we present a rare case of GC without common risk factors and which did not demonstrate the typical clinical features of GC. Furthermore, we reviewed published case reports of GC without abdominal symptoms by searching for these on PubMed/MEDLINE at the end of October 2021 using the following terms: (“gangrenous cholecystitis” or “necrotizing cholecystitis”) AND (“case report” or “case”). The inclusion criteria were as follows: (1) case reports describing the clinical course from admission to treatment; (2) cases without abdominal pain on admission; and (3) full articles with abstracts and reports written in English.

Case report

A 72-year-old female visited our institution for a routine follow-up of pancreatic cancer treatment. She was orally taking TS-1, without severe complications such as neuropathy, and was not taking opioids. She was a non-smoker and had no history of smoking, DM, or CVD. Her vital signs on admission were as follows: temperature, 36.1°C; blood pressure, 80/45 mm Hg; heart rate 100 beats/min; respiratory rate, 16 breaths/min; and O2 saturation in room air, 97%. On physical examination, conjunctival icterus was not detected. Her abdomen was soft and non-tender. The blood test revealed a normal WBC count (5870 cells/μL), elevated C-reactive protein level (8.63 mg/dL), as well as a normal liver function test (aspartate aminotransferase level, 20 U/L and alanine aminotransferase level, 21 U/L) and creatinine level (0.52 mg/dL) (Table 1).
Table 1

Laboratory findings on admission.

HematologyWBCRBC5870/μL3.24 × 106/μL
Hb9.7 g/dL
Ht29.9 %
PLT16.4 × 104/μL
BiochemistryTP6.1 g/dL
AlbASTALTLDHALPγ-GTPAmyCrBUNNaKClCaIPMgGluCRP2.6 g/dL21 IU/L20 IU/L174 IU/L406 IU/L42 IU/L22 IU/L0.52 mg/dL13 mg/dL139 mEq/L3.8 mEq/L105 mEq/L8.2 mg/dL3.2 mg/dL1.9 mg/dL119 mg/dL8.63 mg/dL

WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit; PLT, platelets; TP, total protein; Alb, albumin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; γ-GTP, gamma‐glutamyl transpeptidase; Amy, amylase; Cr, creatinine; BUN, blood urea nitrogen; Na, sodium; K, potassium; Cl, chlorine; Ca, calcium; IP, inorganic phosphorus; Mg, magnesium; Glu, glucose; CRP, C-reactive protein.

Laboratory findings on admission. WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit; PLT, platelets; TP, total protein; Alb, albumin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; γ-GTP, gamma‐glutamyl transpeptidase; Amy, amylase; Cr, creatinine; BUN, blood urea nitrogen; Na, sodium; K, potassium; Cl, chlorine; Ca, calcium; IP, inorganic phosphorus; Mg, magnesium; Glu, glucose; CRP, C-reactive protein. Contrast-enhanced computed tomography (CECT) revealed irregular thickness and partial defect of the gallbladder wall by the contrast agent in the wall. Fluid appeared to project into the liver. An enhanced area of the liver surrounding the gallbladder was detected in the early phase, indicating acute inflammation. A biliary stent (10Fr.-7cm Double Layer Biliary Stent) was placed in the common bile duct, and dilatation was not detected (Fig. 1). GC was suspected based on the above findings; however, we could not reach a definitive diagnosis due to insufficient imaging. US revealed intraluminal membranes in the gallbladder. Contrast-enhanced transabdominal ultrasonography (CEUS) with Sonazoid showed perfusion defects at the bottom of the gallbladder. A low echoic area without perfusion indicating an abscess and high echoic findings indicating parenteral air were not detected around the gallbladder (Fig. 2).
Fig. 1

Findings of the contrast-enhanced computed tomography. Irregular thickness and partial discontinuity of the gallbladder wall with projection of fluid into the liver was observed. (A) Axial image. (B) Coronal image. (C) Sagittal image.

Fig. 2

Contrast-enhanced transabdominal ultrasonography revealed (A) intraluminal membranes and (B) perfusion defects at the bottom of the gallbladder.

Findings of the contrast-enhanced computed tomography. Irregular thickness and partial discontinuity of the gallbladder wall with projection of fluid into the liver was observed. (A) Axial image. (B) Coronal image. (C) Sagittal image. Contrast-enhanced transabdominal ultrasonography revealed (A) intraluminal membranes and (B) perfusion defects at the bottom of the gallbladder. Based on these findings, we diagnosed the patient's condition as GC, and surgical treatment was performed. Initially, laparoscopic cholecystectomy was attempted; however, after detecting intense adhesion of the gallbladder to the lesser omentum, the laparoscopic approach was converted to open cholecystectomy, resulting in complete excision of the gallbladder. A calculus was incarcerated in the cystic duct. Pathological findings showed infiltration of inflammatory cells and severe necrosis of the gallbladder wall, which was consistent with GC. No malignant cells were found in the gallbladder (Fig. 3). The postoperative course was uneventful, and 14 days after surgery, the patient was discharged from our hospital.
Fig. 3

(A, B) Macroscopic findings of the removed gallbladder. Pathological findings showed infiltration of inflammatory cells and severe necrosis of the gallbladder wall. No malignant cells were found in the gallbladder. (C) Hematoxylin and eosin staining under × 40 magnification and (D) × 200 magnification.

(A, B) Macroscopic findings of the removed gallbladder. Pathological findings showed infiltration of inflammatory cells and severe necrosis of the gallbladder wall. No malignant cells were found in the gallbladder. (C) Hematoxylin and eosin staining under × 40 magnification and (D) × 200 magnification.

Discussion

To our knowledge, this is the first report of asymptomatic GC diagnosed using contrast-enhanced ultrasonography in a patient with advanced pancreatic cancer. In this patient, besides asymptomatic status, typical risk factors of GC such as DM, CVD, abnormal liver function test (aspartate aminotransferase and alanine aminotransferase), and high WBC count >15,000 cells/μL were not observed [13]. Thus, without an imaging test, it would have been difficult to predict the presence of GC. In cancer patients, similar to our case, the risk of cholecystitis has been proven to be higher than that in patients without cancer due to malnutrition, leading to gallstone formation and decreased immunity to bacterial infections [16]. The conditions which require placement of a biliary stent, especially pancreatic cancer and cholangiocarcinoma, can increase the risk of subsequent cholecystitis [17]. However, whether cholecystitis patients with cancer have a higher risk of progression to GC remains unclear. Therefore, further accumulation of cases and large-scale investigations are required. In general, patients with GC present with severe symptoms, including abdominal pain and high fever [2]. However, we found a few asymptomatic cases of GC in literature, which are summarized in Table 2. The youngest case was of a 42-year-old female, and all these patients had DM. Additionally, a history of neuropathy and CVD and an elevated WBC count in the blood test were reported in these patients [18,19]. In contrast, the clinical background of our case was not relevant to the known risk factors of GC, except for older age. Therefore, physicians should keep in mind that GC can occur even in patients without risk factors and typical symptoms, and imaging tests should be conducted when patients with carcinoma exhibit unexplained inflammatory findings on blood tests.
Table 2

Summary of previous case reports and the characteristics of each patient with asymptomatic gangrenous cholecystitis.

Case reportauthor (year)AgeSexCountryComorbiditySymptomsRelevant diagnostic methodSurgical treatmentOutcome

Grant et al. (2002) (17)42FAustraliaType 2 diabetes mellitus and renal diseaseNone (examination for renal disease)Transabdominal ultrasonographyLaparoscopic cholecystectomyRecurrence after 3 days
Nidimusili et al. (2013) (18)66MUnited StatesType 2 diabetes mellitus and hypertensionDiscomfort on the left side of the chestComputed tomography (distended gallbladder and air bubbles in the gallbladder neck)Laparoscopic cholecystectomyUneventful
Mehrzad et al. (2018) (4)83MUnited StatesType 2 diabetes mellitusNauseaHepatobiliary iminodiacetic acid scanLaparoscopic cholecystectomyUneventful
Our case (2022)72FJapanPancreatic cancerNone (routine check-up for chemotherapy)Contrast-enhanced transabdominal ultrasonographySurgical resectionUneventful

M, male; F, female.

Summary of previous case reports and the characteristics of each patient with asymptomatic gangrenous cholecystitis. M, male; F, female. Diagnosis of GC is often difficult because typical findings are found only in a small number of GC patients [20]. In previously reported cases, CT, hepatobiliary iminodiacetic acid scan, and US without contrast were adopted for the diagnosis of GC. CT is considered the standard method for the diagnosis of GC. CT findings such as gallbladder distention >4.0 cm, mural striation, and decreased mural enhancement are key findings in the detection of GC [7]. In our patient, due to the lack of these findings in CECT, only the CT findings could not reach a definite diagnosis of GC, and CEUS was able to complete the diagnosis. This can stem from the difficulty of evaluating the enhancement of the gallbladder wall due to its thinness. CECT has been reported to show adequate specificity (96.0%-100.0%) for the diagnosis of GC; however, it has a low sensitivity (29.3%-70.6%) [8]. On the contrary, CEUS is proven to have a sensitivity of 85%–91% and a specificity of 67.5%-84.8% [9]. This higher percentage mainly comes from the greater spatial resolution of US compared to CT and magnetic resonance imaging, as well as the proximity of the gallbladder from the body surface. In our patient, a perfusion defect was confirmed by CEUS, which reported 100% specificity and a positive predictive value [8]. As a result, diagnosis was confirmed, and the patient immediately underwent surgical resection. In addition to its higher diagnostic value, CEUS has several advantages compared to CECT, such as CEUS can be performed in patients with renal dysfunction or allergic reactions to iodinated contrast agents, and CEUS can be performed without radiation exposure. Furthermore, the cost of equipment for CEUS is much lower than that required for CECT. In terms of the surgical approach for GC, some group recommended laparoscopic cholecystectomy due to the short hospital stay, and others suggested that open cholecystectomy can still be an initial option due to its higher safety [21]. Based on these conditions, the most suitable strategy should be an initial approach using laparoscopic cholecystectomy, and if necessary, conversion to open surgery should be made by rapid judgment [22]. Laparoscopic cholecystectomy was performed in previous cases and was also attempted initially for our case. However, the gallbladder of our patient was removed using the open approach because of severe adhesion. In conclusion, we present an asymptomatic case of GC without severe complications of GC, such as perforation. GC can be considered as a differential diagnosis for mild abdominal symptoms; however, GC can also occur without any symptoms in patients with pancreatic cancer. Thus, CEUS is one of the useful modalities for making a definite diagnosis of GC.

Patient consent statement

This study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.
  21 in total

1.  Prognostic factors for the development of gangrenous cholecystitis.

Authors:  Shawn P Fagan; Samir S Awad; Khalil Rahwan; Kenji Hira; Nori Aoki; Kamal M F Itani; David H Berger
Journal:  Am J Surg       Date:  2003-11       Impact factor: 2.565

2.  Identification of risk factors for obstructive cholecystitis following placement of biliary stent in unresectable malignant biliary obstruction: a 5-year retrospective analysis in single center.

Authors:  Jang Han Jung; Se Woo Park; Bomi Hyun; Jin Lee; Dong Hee Koh; Doocheol Chung
Journal:  Surg Endosc       Date:  2020-06-15       Impact factor: 4.584

3.  Gangrenous cholecystitis: a contemporary review.

Authors:  Asvin M Ganapathi; Paul J Speicher; Brian R Englum; Alexander Perez; Douglas S Tyler; Sabino Zani
Journal:  J Surg Res       Date:  2015-03-04       Impact factor: 2.192

4.  Role of laparoscopic cholecystectomy in the management of gangrenous cholecystitis.

Authors:  F A Habib; R B Kolachalam; R Khilnani; O Preventza; V K Mittal
Journal:  Am J Surg       Date:  2001-01       Impact factor: 2.565

5.  Usefulness of contrast-enhanced US in the diagnosis of acute gangrenous cholecystitis: A comparative study with surgical and pathological findings.

Authors:  Tomás Ripollés; María Jesús Martínez-Pérez; Gregorio Martin; José Vizuete; Rosario Martínez-García; Jose Diez; Encarna Martí
Journal:  Eur J Radiol       Date:  2015-10-26       Impact factor: 3.528

6.  Risk of cholecystitis in patients with cancer: a population-based cohort study in Denmark.

Authors:  Reimar W Thomsen; Henrik F Thomsen; Mette Nørgaard; Karynsa Cetin; Joseph K McLaughlin; Robert E Tarone; Jon P Fryzek; Henrik T Sørensen
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

7.  Can gangrenous cholecystitis be prevented?: a plea against a "wait and see" attitude.

Authors:  S Contini; D Corradi; N Busi; L Alessandri; A Pezzarossa; C Scarpignato
Journal:  J Clin Gastroenterol       Date:  2004-09       Impact factor: 3.062

8.  Contrast-enhanced ultrasonography with Sonazoid for diagnosis of gangrenous cholecystitis.

Authors:  Ryousuke Kawai; Jiro Hata; Noriaki Manabe; Hiroshi Imamura; Ai Iida; Rui Nakatou; Nobuko Koyama; Toshihiro Hirai; Yoshito Sadahira
Journal:  J Med Ultrason (2001)       Date:  2015-10-27       Impact factor: 1.314

9.  Leukocytosis of unknown origin: gangrenous cholecystitis.

Authors:  Amara Jyothi Nidimusili; M Chadi Alraies; Naseem Eisa; Abdul Hamid Alraiyes; Khaldoon Shaheen
Journal:  Case Rep Med       Date:  2013-04-01

10.  Old man gallbladder syndrome: Gangrenous cholecystitis in the unsuspected patient population.

Authors:  Teena Dhir; Robert Schiowitz
Journal:  Int J Surg Case Rep       Date:  2015-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.